BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 8135644)

  • 1. Synthesis of N-(9H-xanthen-9-yl)aminoalkanamide and N-(9H-thioxanthen-9-yl)aminoalkanamide derivatives and their in vitro evaluation as potential intercalators and antitumor drugs.
    Filippatos E; Papadaki-Valiraki A; Todoulou O; Jacquemin-Sablon A
    Arch Pharm (Weinheim); 1994 Feb; 327(2):61-6. PubMed ID: 8135644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and antitumor activity of 4-aminomethylthioxanthenone and 5-aminomethylbenzothiopyranoindazole derivatives.
    Perni RB; Wentland MP; Huang JI; Powles RG; Aldous S; Klingbeil KM; Peverly AD; Robinson RG; Corbett TH; Jones JL; Mattes KC; Rake JB; Coughlin SA
    J Med Chem; 1998 Sep; 41(19):3645-54. PubMed ID: 9733489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, cytotoxic activity, NMR study and stereochemical effects of some new pyrano[3,2-b]thioxanthen-6-ones and pyrano[2,3-c]thioxanthen-7-ones.
    Kostakis IK; Pouli N; Marakos P; Mikros E; Skaltsounis AL; Leonce S; Atassi G; Renard P
    Bioorg Med Chem; 2001 Nov; 9(11):2793-802. PubMed ID: 11597459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis, and antiproliferative activity of some new pyrazole-fused amino derivatives of the pyranoxanthenone, pyranothioxanthenone, and pyranoacridone ring systems: a new class of cytotoxic agents.
    Kostakis IK; Magiatis P; Pouli N; Marakos P; Skaltsounis AL; Pratsinis H; Léonce S; Pierré A
    J Med Chem; 2002 Jun; 45(12):2599-609. PubMed ID: 12036369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation of 1-fluoro-4-methyl-9H-[carbonyl-(14) C]thioxanthen-9-one and amine derivatives.
    Javaheri M; Shirvani G; Amini M; Saemian N; Saadatjoo N
    J Labelled Comp Radiopharm; 2016 Jun; 59(8):322-4. PubMed ID: 27157134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and antitumor activity of some new 2-chloroethylnitrosoureas.
    Filippatos E; Papadaki-Valiraki A; Roussakis C; Verbist JF
    Arch Pharm (Weinheim); 1993 Aug; 326(8):451-6. PubMed ID: 8215842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and cytotoxic activity of 2-dialkylaminoethylamino substituted xanthenone and thioxanthenone derivatives.
    Kostakis I; Ghirtis K; Pouli N; Marakos P; Skaltsounis AL; Leonce S; Caignard DH; Atassi G
    Farmaco; 2000; 55(6-7):455-60. PubMed ID: 11204746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis, DNA binding, and biological activity of a series of DNA minor-groove-binding intercalating drugs.
    Bailly C; Pommery N; Houssin R; Henichart JP
    J Pharm Sci; 1989 Nov; 78(11):910-7. PubMed ID: 2621573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analogues of hycanthone and lucanthone as antitumor agents.
    Archer S; Zayed AH; Rej R; Rugino TA
    J Med Chem; 1983 Sep; 26(9):1240-6. PubMed ID: 6887199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential antitumor agents. 57. 2-Phenylquinoline-8-carboxamides as "minimal" DNA-intercalating antitumor agents with in vivo solid tumor activity.
    Atwell GJ; Baguley BC; Denny WA
    J Med Chem; 1989 Feb; 32(2):396-401. PubMed ID: 2913299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new series of ellipticine derivatives (1-(alkylamino)-9-methoxyellipticine). Synthesis, DNA binding, and biological properties.
    Larue L; Rivalle C; Muzard G; Paoletti C; Bisagni E; Paoletti J
    J Med Chem; 1988 Oct; 31(10):1951-6. PubMed ID: 3172128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and structure-activity correlations of the cytotoxic bifunctional 1,4-diamidoanthraquinone derivatives.
    Huang HS; Chiu HF; Lee AL; Guo CL; Yuan CL
    Bioorg Med Chem; 2004 Dec; 12(23):6163-70. PubMed ID: 15519160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interrelationship between affinity for DNA, cytotoxicity and induction of DNA-breaks in cultured L1210 cells for two series of tricyclic intercalators. Simplified analogues of ellipticine derivatives.
    Pierson V; Pierre A; de Cointet P; Nguyen CH; Bisagni E; Gros P
    Biochem Pharmacol; 1989 May; 38(9):1395-406. PubMed ID: 2719718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis, and biological evaluation of new mitonafide derivatives as potential antitumor drugs.
    Antonini I; Volpini R; Dal Ben D; Lambertucci C; Cristalli G
    Bioorg Med Chem; 2008 Sep; 16(18):8440-6. PubMed ID: 18774722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and synthesis of isoindoloquinoline derivatives as potential antitumor agents.
    Lee H; Jeong I; Yang SI
    Arch Pharm Res; 2002 Aug; 25(4):416-20. PubMed ID: 12214847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential antitumor agents. 59. Structure-activity relationships for 2-phenylbenzimidazole-4-carboxamides, a new class of "minimal" DNA-intercalating agents which may not act via topoisomerase II.
    Denny WA; Rewcastle GW; Baguley BC
    J Med Chem; 1990 Feb; 33(2):814-9. PubMed ID: 2153829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Xanthenylacetic Acid Derivatives Effectively Target Lysophosphatidic Acid Receptor 6 to Inhibit Hepatocellular Carcinoma Cell Growth.
    Gnocchi D; Cavalluzzi MM; Mangiatordi GF; Rizzi R; Tortorella C; Spennacchio M; Lentini G; Altomare A; Sabbà C; Mazzocca A
    ChemMedChem; 2021 Jul; 16(13):2121-2129. PubMed ID: 33831272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA intercalators based on (1,10-phenanthrolin-2-yl)isoxazolidin-5-yl core with better growth inhibition and selectivity than cisplatin upon head and neck squamous cells carcinoma.
    Varrica MG; Zagni C; Mineo PG; Floresta G; Monciino G; Pistarà V; Abbadessa A; Nicosia A; Castilho RM; Amata E; Rescifina A
    Eur J Med Chem; 2018 Jan; 143():583-590. PubMed ID: 29207341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analogs of phenothiazines. 6. Stereochemical assignment of isomeric aminoalkylidene derivatives of xanthenes and thioxanthenes with neuropharmacological activity.
    Kaiser C; Warren RJ; Zirkle CL
    J Med Chem; 1974 Jan; 17(1):131-3. PubMed ID: 4808461
    [No Abstract]   [Full Text] [Related]  

  • 20. Synthesis and cytotoxicity of bis-1,3,4-oxadiazoles and bis-pyrazoles derived from 1,4-bis[5-thio-4-substituted-1,2,4-triazol-3-yl]-butane and their DNA binding studies.
    Purohit M; Prasad VV; Mayur CY
    Arch Pharm (Weinheim); 2011 Apr; 344(4):248-54. PubMed ID: 21469174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.